Delivery Order SPE2DB24D8003-SPE2DB25FJTTJ
Award Date
1/31/25
Potential Completion Date
2/3/25
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Dupixent 300 mg/2 ml syringes to support military medical operations. The contract has a ceiling value of $5,495.39 and a performance period extending through January 21, 2025. Dakota Drug, Inc. also holds a larger indefinite delivery contract (IDC) with the DLA, valued at $999,999,999.00, which...
This is a $6,585.81 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the supply of Dupixent 300 mg/2 ml syringes, a pharmaceutical product. This delivery order is part of a larger indefinite-delivery, indefinite-quantity (IDIQ) contract with the DLA Troop Support Medical, which supports the agency's mission of providing comprehensive medical supply chain...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,867.25 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of 4,566,689,724 units of the pharmaceutical product DUPIXENT 300 MG/2 ML SYRINGE 2ML. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, valued at $999,999,999.00, which enables the company to provide...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $4,294.25, is for the delivery of DUPIXENT 300 MG/2 ML SYRINGE 2ML pharmaceutical products. The contract has an ultimate completion date of January 23, 2025, and is a firm fixed-price delivery order. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $5,601.75 contract is for the supply of Dupixent 300 mg/2 ml syringes, with a performance period through August 1, 2024. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $5,158.28, is for the supply of Dupixent 300 mg/2 ml syringes to support the medical supply chain operations of the U.S. Armed Forces. The contract has an ultimate completion date of May 1, 2024 and was awarded on April 30, 2024 without any set-aside designation. As a prime contractor...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $9,480.75 contract is for the supply of Dupixent 300 mg/2 ml syringes, a medication used to treat certain inflammatory conditions. The contract has an ultimate completion date of April 1, 2024. Dakota Drug, Inc. has over two decades of experience providing a wide range of pharmaceutical products and medical...
This is a firm fixed-price delivery order awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical. The $9,839.50 contract is for the delivery of Dupixent 300 mg/2 ml syringes, a pharmaceutical product used to treat various medical conditions. The contract supports the DLA Troop Support Medical's mission of providing comprehensive medical supply chain operations for the U.S. Armed Forces. This delivery order is not...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The $5,784.90 firm fixed-price contract has a period of performance through January 31, 2025. The contract is not set-aside and is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of 4,565,017,975 units of Dupixent 300 mg/2 ml syringes. The $11,203.56 contract has a completion date of June 28, 2024 and does not utilize any set-aside designations. As a prime contractor to the DLA, Dakota Drug, Inc. specializes in supplying a wide range of pharmaceutical...